Ludesi

Ludesi had offered the Redfin service through a partnership agreement with Bio-Rad that the companies announced in May. Bio-Rad is currently "in the process of evaluating how to support" existing Redfin customers.

New Products

Premium

ASMS Focus: New Products from Thermo Fisher, Bruker, Waters, Shimadzu, Agilent, and Bio-Rad

New Products

Premium

Ludesi, Thermo Fisher Scientific

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.